Bonjour, new guests from small-town India
Puneet Dhawan of Accor is brimming with ideas on ways to revive the hospitality sector
China has granted conditional approval for its second Covid-19 vaccine, ahead of the expected emergency approval from the WHO for two of its jabs that would enable the country to step-up global supplies of the shots.
China's drug regulator has given approval for the conditional mass use of the coronavirus vaccine produced by Chinese pharmaceutical firm Sinovac Biotech.
Sinovac Biotech announced on Saturday that CoronaVac, an inactivated vaccine candidate against Covid-19, received authorisation from the National Medical Products Administration for conditional mass use in China.
It is the second locally made vaccine to be given conditional approval. Beijing authorised the state-owned Sinopharm's vaccine in December.
The conditional approval was based on the results of the overseas Phase-III clinical trials of CoronaVac. Final data from the trials has not been made available yet and the results of its efficacy and safety require further confirmation, state-run Global Times said, quoting a Sinovac statement.
The World Health Organisation (WHO) on Friday said two Chinese vaccines are "in a very advanced stage" of its Emergency Use Listing Procedure (EUL) assessment.
The vaccines, produced by Sinovac and Sinopharm, are among the four vaccines in very advanced phase of approval, Mariangela Simao, assistant WHO Director-General for Access to Medicines, Vaccines and Pharmaceuticals, said in Geneva.
A team of experts from the WHO are now already in China, and they "will start inspections next week" as they are currently in quarantine, she said.
So far, only the Pfizer-BioNTech vaccine has received EUL approval. Two other vaccines -- Britain's AstraZeneca and South Korea's SK Bioscience -- are also being assessed, Simao said.
According to WHO, 238 candidate vaccines are being developed worldwide -- 63 of them in clinical trials in various countries.
China is currently testing 16 vaccines which are in different stages of trials. It has vaccinated over 32 million people at home so far.
China has offered to provide 10 million Covid-19 vaccines to COVAX, a global initiative, which aims at ensuring that middle and lower-income countries get timely access to coronavirus vaccines.
Puneet Dhawan of Accor is brimming with ideas on ways to revive the hospitality sector
Citroen’s first vehicle sports a novel design and European interiors. It is also meant to be as comfortable as ...
The pandemic is only the tip of the iceberg that the country’s cash-poor airlines — both regional and national ...
The government is yet to specify the framework of its recently announced old vehicle scrappage policy
This Women’s Day, we discuss the features of a few financial products that aim to help you save, get insured ...
Sensex, Nifty 50 make a strong bounce-back, but test resistances
Avenue Supermarts (₹3,286.1): Makes fresh all-time highIn October last year, the stock of Avenue Supermarts ...
The exchange-traded fund ticks all boxes as an efficient tool to track gold prices
They are the health warriors who battled the Covid-19 pandemic on the ground, and are now the face of the ...
Uzbekistan’s grandest city dazzles tourists with its history, architecture and food
It’s the birth anniversary of Michelangelo di Lodovico Buonarroti Simoni, one of the great artists and ...
Reading in the loo — flipping through anything, really — appears to help the locomotion
Its name is the starting point of a brand’s journey and can make a big difference in the success sweepstakes
Sober spirits are the in thing
A peek into where ad spends went last year and where they are headed tomorrow
Can Swiggy Instamart disrupt the ecommerce groceries space, currently ruled by the Amazons and Big Baskets? ...
Three years after its inception, compliance with GST procedures remains a headache for exporters, job workers ...
Corporate social responsibility (CSR) initiatives of companies are altering the prospects for wooden toys of ...
Aequs Aerospace to create space for large-scale manufacture of toys at Koppal
And it has every reason to smile. Covid-19 has triggered a consumer shift towards branded products as ...
Please Email the Editor